Lung cancer survivors at high risk for recurrence, new lung cancer
the ONA take:
According to a new study presented at the American Thoracic Society (ATS) 2015 International Conference in Denver, Colorado, researchers have found that many lung cancer survivors are at high risk for developing recurrence of their disease or developing another another lung cancer.
For the study, researchers identified 192 lung cancer survivors who underwent surveillance for an average duration of about 8.5 years. Results showed that 38% of patients had developed recurrence or a new lung cancer during this period.
Researchers also found that for every additional pack of cigarettes smoked per year, patients had a 1% increased risk for developing lung cancer again. Other significant risk factors included presence of a nodule on a CT chest scan, premalignant lesions on three autofluorescence bronchoscopy exams anywhere in the central airway, and having recurrence of another non-lung cancer.
"We looked closely at risk factors that may help in predicting cancer recurrence in lung cancer survivors," said study lead author Samjot Dhillon, MD. "What we learned is that patients with a history of lung cancer should have close long-term surveillance so their doctor can detect early on if the cancer is recurring or if there is another cancer developing."
Many lung cancer survivors are at high risk for developing recurrence of their disease or developing another another lung cancer.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
- Drug Classification of Trastuzumab
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|